Press Releases

Date Title and Summary
Toggle Summary Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting
REDWOOD CITY, Calif. , April 20, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced five posters and one oral presentation relating to
Toggle Summary Capnia Names Rajen Dalal to Board of Directors
Appointment Adds Significant Leadership Experience in Medical Devices and Diagnostics REDWOOD CITY, Calif. , April 18, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing
Toggle Summary Capnia Reports Fourth Quarter and Full Year 2015 Financial Results
-Company to Commence Pilot Sales of Serenz® to European Pharmacies in 2Q 2016- -Recently Announced CoSense® Distribution Agreements Covering the U.S. and China - REDWOOD CITY, Calif. , March 24, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and
Toggle Summary Capnia Announces Exclusive Distribution Agreement for Sale of CoSense® in China
Five-year agreement represents significant expansion of CoSense outside the US REDWOOD CITY, Calif. , March 16, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet
Toggle Summary Capnia Receives Re-Certification of European CE Mark for Serenz® for the Treatment of Nasal Allergy Symptoms
Company on track to initiate pilot sales through European Union pharmacies in second quarter 2016 REDWOOD CITY, Calif. , March 14, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics
Toggle Summary Capnia Joins the Consortium for Universal Rh Disease Elimination (CURhE) as Founding Member
Coalition seeks to eradicate Rh Disease/HDFN globally Inaugural meeting to be held today at Stanford University REDWOOD CITY, Calif. , March 07, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and
Toggle Summary Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia
REDWOOD CITY, Calif. , Feb. 25, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced enrollment of the first patient in a Phase 2
Toggle Summary Capnia’s CoSense® ETCO Monitor to be Showcased at the 2016 Mobile World Congress
REDWOOD CITY, Calif. , Feb. 22, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that the Company’s CoSense ETCO Monitor will be
Toggle Summary Capnia Announces Expiration of Series B Warrants
REDWOOD CITY, Calif. and PALO ALTO, Calif. , Feb. 16, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, announced the expiration of the Company’s Series B Warrants as
Toggle Summary Capnia to Present at the 18th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif. , Feb. 01, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar , M.D., Chief Executive Officer, will present at
Print Page RSS Feeds Email Alerts IR Contacts